120 related articles for article (PubMed ID: 22323434)
1. Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.
Rasamny JJ; Allak A; Krook KA; Jo VY; Policarpio-Nicolas ML; Sumner HM; Moskaluk CA; Frierson HF; Jameson MJ
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):923-31. PubMed ID: 22323434
[TBL] [Abstract][Full Text] [Related]
2. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy.
Schrijvers ML; Pattje WJ; Slagter-Menkema L; Mastik MF; Gibcus JH; Langendijk JA; van der Wal JE; van der Laan BF; Schuuring E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1220-6. PubMed ID: 22208968
[TBL] [Abstract][Full Text] [Related]
3. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
5. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy.
Higuchi E; Oridate N; Homma A; Suzuki F; Atago Y; Nagahashi T; Furuta Y; Fukuda S
Head Neck; 2007 Oct; 29(10):940-7. PubMed ID: 17563903
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
9. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
[TBL] [Abstract][Full Text] [Related]
12. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
13. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.
Flezar MS; Kirbis IS; Popović KS; Strojan P
Radiother Oncol; 2009 Dec; 93(3):575-80. PubMed ID: 19850367
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]